In conclusion, we show here that GPR158 RNA and protein expression correlate with distinct diagnostic glioma entities, suggesting that GPR could represent a biomarker for stratifying these tumours (Fig. 7i). This evidence concerns the gene GPR158 and central nervous system cancer.